European
Union
Accessibility tools
Service tools
Language selector
Navigation path
- EUROPA
- Search
Search
-
Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia
-Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia
-
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861
-Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines
-
Vaccines 2.0 - developing the next generation of vaccines
-Vaccines 2.0 - developing the next generation of vaccines